UniQure shares soared on positive AMT-130 Huntington's disease data, but plunged after the FDA reversed its stance on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback